These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 25913118)
1. Synthesis of Schiff base derivatives of 4-(2-aminoethyl)-benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII. Durgun M; Turkmen H; Ceruso M; Supuran CT Bioorg Med Chem Lett; 2015 Jun; 25(11):2377-81. PubMed ID: 25913118 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII. Durgun M; Turkmen H; Ceruso M; Supuran CT Bioorg Med Chem; 2016 Mar; 24(5):982-8. PubMed ID: 26803577 [TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones. Sarikaya B; Ceruso M; Carta F; Supuran CT Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005 [TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors. Inhibition of human cytosolic isoforms I and II with (reduced) Schiff's bases incorporating sulfonamide, carboxylate and carboxymethyl moieties. Nasr G; Cristian A; Barboiu M; Vullo D; Winum JY; Supuran CT Bioorg Med Chem; 2014 May; 22(10):2867-74. PubMed ID: 24746465 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity. Congiu C; Onnis V; Deplano A; Balboni G; Dedeoglu N; Supuran CT Bioorg Med Chem Lett; 2015 Sep; 25(18):3850-3. PubMed ID: 26233435 [TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J; Szafrański K; Vullo D; Supuran CT Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761 [TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors. Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084 [TBL] [Abstract][Full Text] [Related]
11. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII. SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737 [TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996 [TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety. Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with Schiff's bases incorporating iminoureido moieties. Singasane N; Kharkar PS; Ceruso M; Supuran CT; Toraskar MP J Enzyme Inhib Med Chem; 2015 Dec; 30(6):901-7. PubMed ID: 25744513 [TBL] [Abstract][Full Text] [Related]
15. Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors. Angapelly S; Ramya PVS; Angeli A; Del Prete S; Capasso C; Arifuddin M; Supuran CT Bioorg Med Chem; 2017 Oct; 25(20):5726-5732. PubMed ID: 28887000 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds. Petrou A; Geronikaki A; Terzi E; Guler OO; Tuccinardi T; Supuran CT J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1306-11. PubMed ID: 26745009 [TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides. Ozensoy O; Puccetti L; Fasolis G; Arslan O; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Nov; 15(21):4862-6. PubMed ID: 16168653 [TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties. Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360 [TBL] [Abstract][Full Text] [Related]
19. 4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII. Khloya P; Celik G; SitaRam ; Vullo D; Supuran CT; Sharma PK Eur J Med Chem; 2014 Apr; 76():284-90. PubMed ID: 24589484 [TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII. Brzozowski Z; Sławiński J; Vullo D; Supuran CT Eur J Med Chem; 2012 Oct; 56():282-91. PubMed ID: 22910138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]